Work

Micro- and Nanorobots in Cancer Therapy: From Active Drug Delivery to Clinical Translation

Year: 2026
Type: article
Abstract: Micro- and nanorobotic systems represent an emerging approach to overcoming some of the limitations of conventional anticancer drug delivery. Unlike passive nanocarriers, these systems can exploit externally controlled or autonomous propulsion mechanisms to navigate through biological environments, transport therapeutic agents, and potentially improve their distribution within tumour tissues. Various platforms have been investigated, including magnetically actuated microrobots, chemically propelled Janus particles, acoustically responsive systems, and biohybrid devices incorporating bacteria, sperm cells, or microalgae. Recent preclinical investigations have demonstrated the feasibility of delivering therapeutic agents to poorly accessible anatomical compartments, including hypoxic tumour regions and pulmonary metastases. However, substantial challenges remain regarding physiological navigation, drug-loading capacity, pharmacokinetics, biodistribution, biocompatibility, pharmaceutical stability, manufacturing reproducibility, and regulatory evaluation. Importantly, the demonstration of successful propulsion or increased tumour accumulation does not necessarily establish therapeutic efficacy. This review critically examines the technological principles and experimental applications of micro- and nanorobots in oncology, with particular emphasis on pharmaceutical performance and the challenges associated with clinical translation.
Author: Alain ASTIER
Language: English
Open Access status: gold
OpenAlex ID: W7225888463
FWCI:
Cites: 17
Cited by:
Related to: 10